Structures by: Davey R. J.
Total: 71
LoratadineI-m100(L13)
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=27.997(4)Å b=4.918(1)Å c=28.971(4)Å
α=90.00° β=108.987(1)° γ=90.00°
Loratadine-form1
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=27.844(16)Å b=4.867(3)Å c=28.892(16)Å
α=90.00° β=108.98(3)° γ=90.00°
LoratadineI-p80(L13)
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=28.502(15)Å b=5.051(4)Å c=29.231(16)Å
α=90.00° β=109.51(3)° γ=90.00°
LoratadineI-p25
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=28.301(4)Å b=4.998(1)Å c=29.154(4)Å
α=90.00° β=109.217(6)° γ=90.00°
LoratadineI-0deg(L13)
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=28.201(6)Å b=4.9720(10)Å c=29.106(7)Å
α=90.00° β=109.077(10)° γ=90.00°
LoratadineI-m173(L13)
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=27.906(4)Å b=4.8860(10)Å c=28.927(5)Å
α=90.00° β=109.016(5)° γ=90.00°
Ethylenediammonium 3,5-dinitrobenzoate
C7H3N2O6,0.5(C2H10N2)
The journal of physical chemistry. B (2005) 109, 11 5273-5278
a=6.7331(3)Å b=7.8045(3)Å c=10.4466(5)Å
α=94.764(2)° β=108.278(2)° γ=97.433(2)°
4-amino-3-hydroxybenzoic acid
C7H7NO3
CrystEngComm (2020)
a=11.6926(9)Å b=8.1121(7)Å c=14.1796(10)Å
α=90° β=90° γ=90°
4-amino-5-chloro-2-ethoxybenzoic acid
C9H10ClNO3
CrystEngComm (2020)
a=9.7014(12)Å b=14.9141(12)Å c=6.9582(9)Å
α=90° β=109.984(14)° γ=90°
4-amino-2,3,5,6-tetrafluorobenzoic acid acetone solvate
C10H9F4NO3
CrystEngComm (2020)
a=6.5218(10)Å b=17.636(2)Å c=10.0639(14)Å
α=90° β=107.754(14)° γ=90°
4-amino-5-chloro-2-methoxybenzoic acid
C8H8ClNO3
CrystEngComm (2020)
a=7.2780(6)Å b=7.5330(7)Å c=16.2004(11)Å
α=94.713(6)° β=91.340(6)° γ=106.926(7)°
4-amino-3-chlorobenzoic acid
C7H6ClNO2
CrystEngComm (2020)
a=3.7229(3)Å b=11.1634(8)Å c=16.9454(11)Å
α=90° β=95.218(7)° γ=90°
4-amino-2-fluorobenzoic acid
C7H6FNO2
CrystEngComm (2020)
a=14.7711(8)Å b=3.7877(2)Å c=24.3334(12)Å
α=90° β=107.378(4)° γ=90°
4-amino-2,3,5,6-tetrafluorobenzoic acid dioxane solvate
C15H19F4NO6
CrystEngComm (2020)
a=7.0886(2)Å b=18.8246(5)Å c=12.8623(4)Å
α=90° β=92.882(2)° γ=90°
4-amino-2,3,5,6-tetrafluorobenzoic acid
C7H3F4NO2
CrystEngComm (2020)
a=4.1957(2)Å b=14.9867(6)Å c=11.5145(5)Å
α=90° β=97.566(4)° γ=90°
4-aminobenzoic acid dioxane solvate
C18H22N2O6
CrystEngComm (2020)
a=22.4397(9)Å b=20.5326(7)Å c=11.9083(4)Å
α=90° β=105.194(3)° γ=90°
4-amino-3-methylbenzoic acid
2(C8H9NO2)
CrystEngComm (2020)
a=10.7033(4)Å b=8.7280(3)Å c=16.1405(7)Å
α=90° β=95.802(4)° γ=90°
4-aminobenzoic acid acetone solvate
C17H20N2O5
CrystEngComm (2020)
a=5.0395(2)Å b=8.2374(3)Å c=20.4205(7)Å
α=88.805(2)° β=83.313(2)° γ=84.487(2)°
4-amino-2-methylbenzoic acid
C8H9NO2
CrystEngComm (2020)
a=7.74940(14)Å b=8.12614(16)Å c=22.7285(4)Å
α=90° β=90° γ=90°
C15H24O9S3
C15H24O9S3
CrystEngComm (2013) 15, 5 856
a=18.9143(7)Å b=21.0884(9)Å c=5.2773(2)Å
α=90° β=90° γ=90°
P-azoxyanisole form II
CrystEngComm (2008) 10, 3 279
a=14.9227(11)Å b=4.41484(7)Å c=10.3539(3)Å
α=90° β=105.550(3)° γ=90°
4-amino-2-methoxybenzoic acid
C8H9NO3
CrystEngComm (2020)
a=8.1846(7)Å b=13.5952(10)Å c=7.2087(6)Å
α=90° β=109.909(10)° γ=90°
(S)-2-chloromandelic acid
C8H7ClO3
Chem.Commun. (2012) 48, 1976
a=8.0612(4)Å b=7.4986(3)Å c=13.8910(6)Å
α=90.00° β=105.997(5)° γ=90.00°
Isonicotinamide 4-hydroxy-3-nitrobenzoic acid co-crystal
C7H5NO5,C6H6N2O
Physical chemistry chemical physics : PCCP (2014) 16, 3 1150-1160
a=29.713(4)Å b=4.9822(2)Å c=25.526(4)Å
α=90.00° β=136.84(3)° γ=90.00°
Pyridinium-4-carboxamide 2,4,6-trihydroxybenzoate
C7H5O5,C6H7N2O
Physical chemistry chemical physics : PCCP (2014) 16, 3 1150-1160
a=12.8093(14)Å b=13.1563(12)Å c=7.4708(8)Å
α=90.00° β=90.00° γ=90.00°
C15H18Cl1N3O1
C15H18Cl1N3O1
CrystEngComm (2014) 16, 21 4377
a=5.7765(6)Å b=13.4566(13)Å c=19.456(2)Å
α=90° β=90° γ=90°
C7H7NO2
C7H7NO2
CrystEngComm (2015) 17, 5 1015
a=18.5620(11)Å b=3.7320(2)Å c=18.5680(12)Å
α=90° β=93.993(6)° γ=90°
C7H7NO2
C7H7NO2
CrystEngComm (2015) 17, 5 1015
a=6.2436(9)Å b=8.4577(12)Å c=12.3655(17)Å
α=90° β=100.198(15)° γ=90°
Loratadine-form2-He
C22H23ClN2O2
Faraday discussions (2018) 211, 0 209-234
a=35.652(10)Å b=5.206(2)Å c=22.743(6)Å
α=90.00° β=117.418(14)° γ=90.00°
(1R, 2S)-(-)-ephedrine besylate
C16H20O4S1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.7214(3)Å b=20.8336(11)Å c=6.9188(5)Å
α=90° β=98.409(2)° γ=90°
(1R, 2S)-(-)-ephedrine adipate
C16H25N1O5
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.82900(10)Å b=13.5440(4)Å c=21.7000(7)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine acetate
C12H19N1O3
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.96420(10)Å b=10.4125(2)Å c=11.7403(4)Å
α=108.1750(10)° β=104.5600(10)° γ=104.087(2)°
(1R, 2S)-(-)-ephedrine edisylate
C22H36N2O8S2
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.71080(10)Å b=34.0651(7)Å c=6.6590(2)Å
α=90° β=90.09° γ=90°
(1R, 2S)-(-)-ephedrine
C10H16N1O1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.6851(4)Å b=7.7047(5)Å c=22.4819(17)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine esylate
C12H21N1O4S1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.4877(7)Å b=11.9057(17)Å c=22.639(4)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine hydrochloride
C10H14Cl1N1O1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=7.2557(3)Å b=6.1228(3)Å c=12.5486(6)Å
α=90° β=102.223(2)° γ=90°
(1R, 2S)-(-)-ephedrine L-(-)-malate
C14H21N1O6
Acta Crystallographica Section B (2006) 62, 3 498-505
a=6.1312(6)Å b=9.1719(10)Å c=13.7393(17)Å
α=90° β=100.909(4)° γ=90°
(1R, 2S)-(-)-ephedrine maleate monohydrate
C12H12N1O4
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.6370(2)Å b=13.4950(5)Å c=20.5250(5)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine mesylate
C11H19N1O4S1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=14.287(2)Å b=6.1075(7)Å c=14.993(2)Å
α=90° β=93.211(6)° γ=90°
(1R, 2S)-(-)-ephedrine dihydrogen phosphate
C10H16N1O5P1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=14.6992(10)Å b=5.6433(4)Å c=15.2432(14)Å
α=90° β=97.333(3)° γ=90°
(1R, 2S)-(-)-ephedrine bisulfate
C10H18N1O5S1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=30.9967(17)Å b=6.9861(4)Å c=5.6170(3)Å
α=90° β=93.354(3)° γ=90°
(1R, 2S)-(-)-ephedrine L-(+)-tartrate monohydrate
C14H23N1O8
Acta Crystallographica Section B (2006) 62, 3 498-505
a=6.6220(2)Å b=7.4620(3)Å c=33.2160(15)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine P-tosylate
C17H23N1O7S1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.7491(2)Å b=7.1665(2)Å c=42.0343(9)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine malonate
C11H17N1O3
Acta Crystallographica Section B (2006) 62, 3 498-505
a=15.1190(14)Å b=5.7840(7)Å c=13.8788(15)Å
α=90° β=105.765(7)° γ=90°
Sodium 3,5-dinitrobenzoate
Na,C7H3N2O6
Acta Crystallographica Section E (2005) 61, 6 m1131-m1132
a=10.7701(5)Å b=10.7701(5)Å c=6.3526(2)Å
α=90° β=90° γ=120°
Ethylenediaminium--3,5-dinitrobenzoate--3,5-dinitrobenzoic acid (1/2/2), C~2~H~10~N~2~^2+^.2C~7~H~3~N~2~O~6~^-^.2C~7~H~4~N~2~O~6~
C2H10N22,2(C7H3N2O6),2(C7H4N2O6)
Acta Crystallographica Section E (2005) 61, 6 o1823-o1825
a=7.0452(3)Å b=11.2345(4)Å c=11.7627(5)Å
α=91.838(2)° β=96.230(2)° γ=98.7100(10)°
C16H14O5
C16H14O5
Acta Crystallographica Section E (2004) 60, 2 o232-o233
a=10.5196(4)Å b=6.4129(3)Å c=11.7201(7)Å
α=90° β=114.107(2)° γ=90°
C15H14O3
C15H14O3
Acta Crystallographica Section E (2004) 60, 11 o1984-o1986
a=8.0627(3)Å b=5.6494(2)Å c=26.7944(11)Å
α=90° β=94.1300(10)° γ=90°
C20H13NO4
C20H13NO4
Acta Crystallographica Section C (1992) 48, 2 321-323
a=14.972(3)Å b=5.1410(10)Å c=19.853(3)Å
α=90° β=94.15(2)° γ=90°
C17H17ClN4O2
C17H17ClN4O2
Acta Crystallographica Section C (1992) 48, 2 323-325
a=7.586(2)Å b=11.429(4)Å c=19.592(8)Å
α=90° β=93.52(3)° γ=90°
C13H8F2O
C13H8F2O
Acta Crystallographica Section C (1994) 50, 2 254-255
a=23.184(7)Å b=6.170(10)Å c=7.409(9)Å
α=90.° β=79.868(9)° γ=90.°
C21H25NO
C21H25NO
Acta Crystallographica Section C (2005) 61, 3 o143-o144
a=73.814(15)Å b=7.0080(14)Å c=6.8710(14)Å
α=90° β=94.98(3)° γ=90°
2-ethoxybenzamide
C9H11NO2
Crystal Growth & Design (2012) 12, 12 6110
a=5.0512(8)Å b=12.027(3)Å c=14.251(3)Å
α=90.00° β=96.774(17)° γ=90.00°
2-ethoxybenzamide
C9H11NO2
Crystal Growth & Design (2012) 12, 12 6110
a=5.0339(5)Å b=11.8782(13)Å c=14.1229(15)Å
α=90.00° β=96.590(10)° γ=90.00°
Ethenzamide - 2,6-dihydroxybenzoic acid
C16H17NO6
Crystal Growth & Design (2012) 12, 12 6110
a=7.3241(7)Å b=13.5843(9)Å c=14.8048(10)Å
α=90.00° β=95.715(7)° γ=90.00°
2-ethoxybenzamide 3,5-dichlorobenzoic acid
C9H11NO2,C7H4Cl2O2
Crystal Growth & Design (2012) 12, 12 6110
a=14.9456(9)Å b=14.5611(6)Å c=7.7198(5)Å
α=90.00° β=103.794(6)° γ=90.00°
Dihydrocarbamazepine saccharin
C15H14N2O,C7H5NO3S
Crystal Growth & Design (2011) 11, 2 449
a=7.5822(12)Å b=25.215(6)Å c=10.554(3)Å
α=90.00° β=105.878(8)° γ=90.00°
Cyheptamide saccharin
C16H15NO,C7H5NO3S
Crystal Growth & Design (2011) 11, 2 449
a=7.7883(3)Å b=24.7090(9)Å c=10.5827(4)Å
α=90.00° β=106.951(2)° γ=90.00°
4-amino3-nitrobenzoic acid
C7H6N2O4
Crystal Growth & Design (2010) 10, 2 726
a=6.9476(6)Å b=10.5032(7)Å c=10.4856(8)Å
α=90.00° β=104.845(8)° γ=90.00°
4-amino3methoxybenzoic acid:4-hydroxy3nitrobenzoic acid
C8H9NO3,C7H5NO5
Crystal Growth & Design (2010) 10, 2 726
a=7.174(5)Å b=7.390(5)Å c=14.810(5)Å
α=87.838(5)° β=77.665(5)° γ=73.057(5)°
4-amino3-methoxybenzoic acid, 4-amino3methoxybenzoate, 3-nitrophthalic acid complex
C8H4N1O6,C8H10NO3,C8H9NO3
Crystal Growth & Design (2010) 10, 2 726
a=7.1029(8)Å b=9.1205(10)Å c=18.4444(19)Å
α=80.379(9)° β=81.896(9)° γ=88.629(9)°
4-aminobenzoic acid/4-hydroxy 3-nitrobenzoic acid co-crystal
C7H7NO2,C7H5NO5
Crystal Growth & Design (2010) 10, 2 726
a=9.0165(7)Å b=16.5146(12)Å c=9.4128(7)Å
α=90.00° β=102.349(7)° γ=90.00°
C2H5N1O2
C2H5N1O2
Crystal Growth & Design (2003) 3, 1 53
a=5.0785(4)Å b=6.1923(5)Å c=5.3869(5)Å
α=90° β=113.346(3)° γ=90°
C15H12N2O8
C15H12N2O8
Crystal Growth & Design (2009) 9, 3 1278
a=13.2862(8)Å b=7.9802(4)Å c=14.7299(12)Å
α=90° β=109.959(2)° γ=90°
4-aminobenzoic acid 4-cyanobenzoic acid
C15H12N2O4
Crystal Growth & Design (2009) 9, 3 1278
a=7.4406(4)Å b=7.4008(4)Å c=24.5392(16)Å
α=90° β=99.012(2)° γ=90°
(1R, 2S)-(-)-ephedrine glycolate
C12H19N1O4
Acta Crystallographica Section B (2006) 62, 3 498-505
a=9.5946(4)Å b=6.0474(3)Å c=10.8255(5)Å
α=90° β=101.607(2)° γ=90°
(1R, 2S)-(-)-ephedrine hemihydrate
C10H15N1O1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=7.3639(4)Å b=11.2551(6)Å c=24.1442(16)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine nitrate
C10H14N2O4
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.5309(4)Å b=6.8501(6)Å c=15.6906(13)Å
α=90° β=97.243(6)° γ=90°
(1R, 2S)-(-)-ephedrine L-(+)-tartrate trihydrate
C24H42N2O11
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.9373(2)Å b=7.0594(2)Å c=18.3791(8)Å
α=80.2540(10)° β=88.527(2)° γ=66.247(2)°
3,5-diaminobenzoic acid 3,5-dinitrobenozate
C7H9N2O2,C7H3N2O6
Crystal Growth & Design (2010) 10, 2 726
a=7.0409(5)Å b=14.9622(11)Å c=13.8320(10)Å
α=90.00° β=101.669(7)° γ=90.00°
4-aminobenzoic acid 3,5-dinitrobenzoic acid
C14H11N3O8
Crystal Growth & Design (2009) 9, 3 1278
a=6.918(2)Å b=20.663(7)Å c=21.301(6)Å
α=90° β=90° γ=90°